Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Endometrial Neoplasms × 30 days × Clear all

Phase

Phase 1 27 Phase 2 19 Phase 1/2 19 Phase NA 12 Phase 3 8 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Myasthenia Gravis 4 Lung Neoplasms 4 Urinary Bladder Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Acute 3 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Melanoma 2 Liposarcoma 2 Leukemia, Myelomonocytic, Chronic 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Ulcer 1

Interventions

spartalizumab 1 sintilimab 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Letrozole 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07319429 2026-03-13

FEMUS

Fudan University

Phase 2/3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡